Ovid Therapeutics Inc
Research Ovid Therapeutics Inc (OVID) on Bullrun: market cap USD 537.64M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerOVID
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 537.64M
- Financial periodQ1 2026
- RevenueUSD 0
- Net income-USD 24.17M
- Free cash flow-USD 41.95M
Valuation Snapshot
latest market cap is USD 537.64M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 7.25M | -USD 17.40M | -USD 38.33M | n/a | -0.31 | USD 13.15M | USD 13.42M | USD 130.66M |
| FY2024 | USD 566.00K | -USD 26.40M | -USD 56.03M | n/a | -0.38 | USD 26.30M | USD 14.76M | USD 68.23M |
| FY2023 | USD 392.00K | -USD 52.30M | -USD 45.82M | n/a | -0.74 | USD 27.04M | USD 16.00M | USD 87.80M |
| FY2022 | USD 1.50M | -USD 54.17M | -USD 56.45M | n/a | -0.77 | USD 44.87M | USD 15.97M | USD 132.27M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 537.64M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 212.20M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 66.04M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 227.59M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 131.07M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 225.87M | 1.8 | n/a | n/a |
About Ovid Therapeutics Inc
Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of small molecule medicines for brain disorders including epilepsies and seizure-related neurological disorders in the United States. The company is developing OV329, a GABA-AT inhibitor which is in Phase 1 clinical trials for the treatment of adult and infant drug-resistant epilepsies;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Ovid Therapeutics Inc's market cap?
Ovid Therapeutics Inc's market capitalization is USD 537.64M.
What does Ovid Therapeutics Inc do?
Ovid Therapeutics Inc., a biopharmaceutical company, engages in the development of small molecule medicines for brain disorders including epilepsies and seizure-related neurological disorders in the United States.